Prime Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	5.98	2.98	-	-	-	5.21
Cost of Revenue	160.03	155.29	147.91	86.73	70.55	2.98
Gross Profit	-154.05	-152.31	-147.91	-86.73	-70.55	2.23
Selling, General & Admin	49.91	50.16	43.39	29.82	13.92	3.16
Operating Expenses	49.91	50.16	43.39	29.82	13.92	3.16
Operating Income	-203.96	-202.47	-191.29	-116.54	-84.47	-0.93
Interest & Investment Income	4.6	3.52	2.81	-	-	-
Other Non Operating Income (Expenses)	0.14	0.04	0.27	1.9	-80.99	-11.48
EBT Excluding Unusual Items	-199.22	-198.9	-188.21	-114.64	-165.46	-12.41
Gain (Loss) on Sale of Investments	1.88	3.02	3.3	-8.13	-0.39	10.87
Other Unusual Items	-	-	-13.5	-	-	-
Pretax Income	-197.34	-195.88	-198.41	-122.77	-165.85	-1.54
Income Tax Expense	-	-	-0.28	-0.95	-0.49	1.87
Net Income	-197.34	-195.88	-198.13	-121.82	-165.37	-3.41
Preferred Dividends & Other Adjustments	-	-	-	20.19	18.75	1.65
Net Income to Common	-197.34	-195.88	-198.13	-142.01	-184.12	-5.06
Shares Outstanding (Basic)	137	119	91	34	13	3
Shares Outstanding (Diluted)	137	119	91	34	13	3
Shares Change (YoY)	25.86%	30.37%	168.41%	161.23%	391.47%	77.53%
EPS (Basic)	-1.44	-1.65	-2.18	-4.19	-14.19	-1.91
EPS (Diluted)	-1.44	-1.65	-2.18	-4.19	-14.19	-1.91
Free Cash Flow	-115.1	-130.16	-174.14	-147.92	-38.23	-6.18
Free Cash Flow Per Share	-0.84	-1.10	-1.91	-4.37	-2.95	-2.34
Gross Margin	-	-	-	-	-	42.80%
Operating Margin	-3412.48%	-6787.36%	-	-	-	-17.89%
Profit Margin	-3301.64%	-6566.61%	-	-	-	-97.02%
Free Cash Flow Margin	-1925.63%	-4363.36%	-	-	-	-118.68%
EBITDA	-196.8	-196.34	-186.64	-114.32	-83.91	-0.89
EBITDA Margin	-	-	-	-	-	-17.06%
D&A For EBITDA	7.16	6.13	4.65	2.22	0.57	0.04
EBIT	-203.96	-202.47	-191.29	-116.54	-84.47	-0.93
EBIT Margin	-	-	-	-	-	-17.89%
Revenue as Reported	5.98	2.98	-	-	-	-

Updated Nov 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q